# CD19 CAR T cell therapy alters disease-associated immune signatures in multiple sclerosis

Source: [cell.com](https://www.cell.com/cell/fulltext/S0092-8674(26)01337-1?rss=yes) · 2026-11-19 · Life
Page: https://themorning.science/story/cd19-car-t-cell-therapy-alters-disease-associated-immune-signatures-in-multiple-105d8d217f07d4b4
Kind: research · Impact: medium

## In brief

- A preliminary case series of five people with multiple sclerosis received CD19 CAR T cell therapy.
- CAR T cells expanded in the cerebrospinal fluid (CSF) of these individuals.
- CSF disease biomarkers showed sustained reductions after treatment.

## Why it matters

The results suggest CD19 CAR T cell therapy can reach and alter immune activity in the central nervous system in multiple sclerosis, but the evidence comes from only five people and is preliminary.

## Timeline

- 2026-11-19: Study published in Cell describing CD19 CAR T cell effects in five people with multiple sclerosis

## Coverage

- [CD19 CAR T cell therapy alters disease-associated immune signatures in multiple sclerosis](https://www.cell.com/cell/fulltext/S0092-8674(26)01337-1?rss=yes) — cell.com, 2026-11-19

Tags: multiple sclerosis, car t cells, cd19, immunotherapy, cerebrospinal fluid

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
